Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis

Emmi Puuvuori, Yunbing Shen, Gry Hulsart-Billström, Bogdan Mitran, Bo Zhang, Pierre Cheung, Olivia Wegrzyniak, Sofie Ingvast, Jonas Persson, Stefan Ståhl, Olle Korsgren, John Löfblom, Fredrik Wermeling and Olof Eriksson
Journal of Nuclear Medicine February 2024, 65 (2) 294-299; DOI: https://doi.org/10.2967/jnumed.123.266336
Emmi Puuvuori
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunbing Shen
2Center for Molecular Medicine, Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gry Hulsart-Billström
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bogdan Mitran
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
3Antaros Medical AB, Mölndal, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Zhang
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Cheung
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivia Wegrzyniak
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofie Ingvast
4Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Persson
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
5Department of Protein Science, Division of Protein Engineering, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Ståhl
5Department of Protein Science, Division of Protein Engineering, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olle Korsgren
4Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Löfblom
5Department of Protein Science, Division of Protein Engineering, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Wermeling
2Center for Molecular Medicine, Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olof Eriksson
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
3Antaros Medical AB, Mölndal, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 2 294-299
DOI 
https://doi.org/10.2967/jnumed.123.266336
PubMed 
38050119

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication July 12, 2023
  • Revision received October 10, 2023
  • Published online February 1, 2024.

Article Versions

  • previous version (November 30, 2023 - 08:22).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Emmi Puuvuori*,1,
  2. Yunbing Shen*,2,
  3. Gry Hulsart-Billström1,
  4. Bogdan Mitran1,3,
  5. Bo Zhang1,
  6. Pierre Cheung1,
  7. Olivia Wegrzyniak1,
  8. Sofie Ingvast4,
  9. Jonas Persson1,5,
  10. Stefan Ståhl5,
  11. Olle Korsgren4,
  12. John Löfblom5,
  13. Fredrik Wermeling†,2 and
  14. Olof Eriksson†,1,3
  1. 1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  2. 2Center for Molecular Medicine, Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden;
  3. 3Antaros Medical AB, Mölndal, Sweden;
  4. 4Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; and
  5. 5Department of Protein Science, Division of Protein Engineering, KTH Royal Institute of Technology, Stockholm, Sweden
  1. For correspondence or reprints, contact Fredrik Wermeling (fredrik.wermeling{at}ki.se) or Olof Eriksson (olof.eriksson{at}ilk.uu.se).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity
    Eva Peeters, Evelien A J van Genugten, Sandra Heskamp, I Jolanda M de Vries, Carla van Herpen, Hans J P M Koenen, Manfred Kneilling, Rachel S van der Post, Willemijn A van Dop, Harm Westdorp, Erik Aarntzen
    Journal for ImmunoTherapy of Cancer 2025 13 5
  • Imaging antigen processing and presentation in cancer
    Doreen Lau, Tim Elliott
    Immunotherapy Advances 2024 5 1
  • Nuclear Molecular Imaging for Evaluating T Cell Exhaustion
    Huimin Zhou, Guangfa Bao, Jun Zhao, Xiaohua Zhu
    Molecular Pharmaceutics 2025 22 1

Article usage

Article usage: November 2023 to April 2025

AbstractFullPdf
Nov 202325172
Dec 2023320229102
Jan 202420017757
Feb 2024382701693
Mar 202413829991
Apr 20249217966
May 20242353315
Jun 20242284716
Jul 202420212825
Aug 20243517838
Sep 2024347143
Oct 2024319847
Nov 20243210054
Dec 2024237739
Jan 2025225422
Feb 2025219538
Mar 2025208140
Apr 2025136953
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (2)
Journal of Nuclear Medicine
Vol. 65, Issue 2
February 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis
Emmi Puuvuori, Yunbing Shen, Gry Hulsart-Billström, Bogdan Mitran, Bo Zhang, Pierre Cheung, Olivia Wegrzyniak, Sofie Ingvast, Jonas Persson, Stefan Ståhl, Olle Korsgren, John Löfblom, Fredrik Wermeling, Olof Eriksson
Journal of Nuclear Medicine Feb 2024, 65 (2) 294-299; DOI: 10.2967/jnumed.123.266336

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis
Emmi Puuvuori, Yunbing Shen, Gry Hulsart-Billström, Bogdan Mitran, Bo Zhang, Pierre Cheung, Olivia Wegrzyniak, Sofie Ingvast, Jonas Persson, Stefan Ståhl, Olle Korsgren, John Löfblom, Fredrik Wermeling, Olof Eriksson
Journal of Nuclear Medicine Feb 2024, 65 (2) 294-299; DOI: 10.2967/jnumed.123.266336
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity
  • Google Scholar

More in this TOC Section

  • In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
  • 161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas
  • 212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
Show more Basic Science Investigation

Similar Articles

Keywords

  • rheumatoid arthritis
  • inflammatory arthritis
  • PET
  • CD69
  • inflammation
SNMMI

© 2025 SNMMI

Powered by HighWire